before submitting an investigational new drug application to the FDA several critical studies must be completed first we conduct preclinical studies which include laboratory and animal testing to assess safety and efficacy these studies help us understand how the drug behaves in a living organism next we gather pharmacokinetic data which reveals how the drug is absorbed distributed metabolized and excreted toxicology studies are also essential identifying any potential harmful effects finally we compile all this data into a comprehensive package ensuring we meet FDA guidelines this rigorous process is vital for patient safety and successful drug development